Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis
Status:
Completed
Trial end date:
1998-09-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Compare the safety and efficacy of monolaurin cream versus a placebo vehicle
cream in suppressing the signs of nonbullous congenital ichthyosiform erythroderma.
II. Assess the incidence of posttreatment rebound or recrudescence in patients with
congenital ichthyosis.
III. Evaluate the long term safety of monolaurin cream with whole body application in these
patients.